Moreover, MAdCAM-1 has been discovered to be expressed in the liver in persons with diet-induced nonalcoholic steatohepatitis (NASH) and the loss of this molecule may even contribute to the decreased risk of NASH development. Here, MADCAM1 is linked to metabolic dysfunction-associated steatohepatitis.